Executive Profile*

Tyler F. Jacks Ph.D.

AgeTotal Calculated CompensationThis person is connected to 80 board members in 5 different organizations across 7 different industries.

See Board Relationships
55--

Background*

Dr. Tyler F. Jacks, Ph.D., serves as Director of the Center for Cancer Research of the Massachusetts Institute of Technology. Dr. Jacks serves as Professor of Biology at MIT. He co-founded T2 Biosystems, Inc., in 2006. He joined at MIT in 1992 as a faculty. He served as Member of Scientific Advisory Board at Aveo Pharmaceuticals, Inc. He served as the Chairman of the Scientific Advisory Board of NexGenix Pharmaceuticals Holdings, Inc. He serves as Co-Chairman of Research ...

Read Full Background

Corporate Headquarters*

615 Chestnut Street
Philadelphia, Pennsylvania 19106-4404

United States

Phone: 215-440-9300
Fax: 215-440-9313

Board Members Memberships*

Director
2009-Present
Director and Member of Scientific Advisory Board
2012-Present
Director

Education*

Unknown/Other Education
University of California
BA 1983
Harvard College
PhD
University of California-San Francisco

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule, Inc.
$489.3K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.3M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.2M GBP
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥495.0M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.